Company: BIVIW
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001520138-25-000343
Chunk: 51

Company: BIOVIE INC.
Filing Date: 2025-11-10
Form: 10-Q
Item: Part I, Item 8
Chunk 51
---
    $- 

The Company recorded stock-based compensation
expense relating to the vesting of stock options of approximately $268,000 and $119,000 for the three months ended September 30, 2025
and 2024, respectively.

Restricted stock units:

On September 2, 2025, (the “Grant Date”)
the Company awarded a total of 1,500 RSUs to a consultant at the grant date fair value of $1.58. The RSUs vest in five equal installments
at the Grant Date and over the next four calendar quarters beginning December 31, 2025.

    15

The following table summarizes vesting of restricted
stock units:

    Schedule of unvested of restricted stock units 

    Number of Shares  
    Weighted Average Grant Date Fair Value Per Share 
  
    Unvested at June 30, 2025 
     7,212  
    $116.41 
  
    Granted 
     1,500  
     1.58 
  
    Vested 
     (3,255) 
     22.20 
  
    Unvested at September 30, 2025 
     5,457  
    $141.05 

The total stock-based compensation expense from
restricted stock units for the three months ended September 30, 2025 and 2024 was approximately $271,000 and $301,000, respectively.  

    16

Stock Warrants

The following table summarizes the warrants activity during the three
months ended September 30, 2025:

    Summary of warrants activity 

    Number of Shares  
    Weighted Average Exercise Price  
    Weighted Average Remaining Life (Years)  
    Aggregate Intrinsic Value 
  
    Outstanding and exercisable at June 30, 2025 
     960,098  
    $35.02  
     4.1  
    $- 
  
    Granted 
     6,967,300  
     2.50  
     5.0  
     - 
  
    Expired 
     (360) 
     1,250.00  
     -  
     - 
  
    Outstanding and exercisable at September 30, 2025 
     7,927,038  
    $6.28  
     4.7